Search

Type

Audience

Category

Issue

Last updated

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.

Displaying 1 - 12 of 12 items.

" " Authorization of Janssen COVID-19 Vaccine with English-only Vial and Carton Labels
… Authorization of Janssen COVID-19 Vaccine with English-only Vial and Carton Labels Starting … date information during the initial distribution of the Janssen COVID-19 Vaccine. Audience Healthcare professionals …
AlertHealth professional risk communication | 2021-03-08
" " Importation of Janssen COVID-19 Vaccine with Two Types of English-only Vial and Carton Labels
… Importation of Janssen COVID-19 Vaccine with Two Types of English-only Vial and Carton … date information during the initial distribution of the Janssen COVID-19 Vaccine. Please note: Important safety …
AlertHealth professional risk communication | 2021-04-26
" " Importation of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels (US-Labelled Supply)
… Importation of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels … during the initial distribution of the AstraZeneca COVID-19 Vaccine (US-labelled vaccine supplies) Audience …
AlertHealth professional risk communication | 2021-03-31
" " COVID-19 Vaccine Moderna: Updated English-only Global Vial and Carton Labels and Post-Market Adverse Reaction Information
… COVID-19 Vaccine Moderna: Updated English-only Global Vial and … (the Canadian importer and distributor) is distributing COVID-19 Vaccine Moderna doses directly to vaccination locations …
AlertHealth professional risk communication | 2021-02-22
" " Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels
… Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels Starting … during the initial distribution of the AstraZeneca COVID-19 Vaccine. Audiences Healthcare professionals …
AlertHealth professional risk communication | 2021-03-01
" " AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
… AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome … have been reported following vaccination with AstraZeneca COVID-19 Vaccine. A history of CLS was noted in some of the …
AlertHealth professional risk communication | 2021-06-29
" " AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia
… AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with … very rarely following vaccination with the AstraZeneca COVID-19 Vaccine. Health Canada has assessed the available data on …
AlertHealth professional risk communication | 2021-03-24
" " Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market Adverse Reaction Information
… Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market … of Use (POUs). Pfizer is distributing Pfizer-BioNTech COVID-19 Vaccine doses directly to POUs, vaccination …
AlertHealth professional risk communication | 2021-02-09
" " Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic
… of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic Starting date: September 22, 2021 Posting date: … Sale and Advertising of Drugs for Use in Relation to COVID-19 . Sotrovimab is indicated for the treatment of mild …
AlertHealth professional risk communication | 2021-10-04
" " Pfizer-BioNTech COVID-19 Vaccine: Updated Storage and Transportation Conditions
… Pfizer-BioNTech COVID-19 Vaccine: Updated Storage and Transportation Conditions … of Use (POUs). Pfizer is distributing Pfizer-BioNTech COVID-19 Vaccine doses directly to POUs, vaccination locations …
AlertHealth professional risk communication | 2021-03-08
" " Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
… with English-only Labels for Use in Relation to the COVID-19 Pandemic Starting date: July 30, 2021 Posting date: July … Sale and Advertising of Drugs for Use in Relation to COVID-19 . Casirivimab and imdevimab, to be administered …
AlertHealth professional risk communication | 2021-07-30
" " Recall of certain hand sanitizers that may pose health risks (Part 1 - June 17, 2020 to March 24, 2021)
… and have health concerns To help limit the spread of COVID-19, wash your hands often with soap and water for at least 20 … (DIN) but have been accepted for use in Canada during the COVID-19 pandemic Report any health product  adverse events …
AlertPublic advisory | 2021-03-24
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.